- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased hematocrit / IMPC
- increased leukocyte cell number / IMPC
- increased mean platelet volume / IMPC
- decreased circulating triglyceride level / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating chloride level / IMPC
- thrombocytopenia / IMPC
- increased lean body mass / IMPC
- decreased circulating iron level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating bilirubin level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating glucose level / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- decreased circulating total protein level / IMPC
- increased circulating sodium level / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- increased circulating amylase level / IMPC
- decreased total body fat amount / IMPC
- increased red blood cell distribution width / IMPC
C57BL/6N-Slc29a3em1(IMPC)Wtsi/WtsiCnrm
Status | Available to order |
EMMA ID | EM:13448 |
Citation information | RRID:IMSR_EM:13448 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Slc29a3em1(IMPC)Wtsi/WtsiCnrm |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Slc29a3em1(IMPC)Wtsi |
Gene/Transgene symbol | Slc29a3 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- H syndrome / Orphanet_168569
- Dysosteosclerosis / Orphanet_1782
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal liver morphology / IMPC
- increased lean body mass / IMPC
- small uterus / IMPC
- enlarged liver / IMPC
- abnormal stomach morphology / IMPC
- decreased circulating HDL cholesterol level / IMPC
- hyperplasia / IMPC
- decreased erythrocyte cell number / IMPC
- abnormal lymph node morphology / IMPC
- increased spleen weight / IMPC
- enlarged spleen / IMPC
- enlarged lymph nodes / IMPC
- increased circulating chloride level / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- abnormal uterus morphology / IMPC
- enlarged duodenum / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating aspartate transaminase level / IMPC
- small kidney / IMPC
- prolonged RR interval / IMPC
- decreased circulating cholesterol level / IMPC
- increased red blood cell distribution width / IMPC
- increased startle reflex / IMPC
- enlarged ileum / IMPC
- abnormal skin morphology / IMPC
- abnormal kidney morphology / IMPC
- increased circulating alanine transaminase level / IMPC
- abnormal thymus morphology / IMPC
- abnormal cecum morphology / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- fibrosis / IMPC
- atrophy / IMPC
- abnormal brain morphology / IMPC
- decreased total body fat amount / IMPC
- abnormal spleen morphology / IMPC
- increased circulating sodium level / IMPC
- small seminal vesicle / IMPC
- abnormal lung morphology / IMPC
- distended jejunum / IMPC
- increased circulating amylase level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating total protein level / IMPC
- increased circulating bilirubin level / IMPC
- abnormal seminal vesicle morphology / IMPC
- decreased hemoglobin content / IMPC
- decreased circulating LDL cholesterol level / IMPC
- thrombocytopenia / IMPC
- enlarged cecum / IMPC
- abnormal caudal vertebrae morphology / IMPC
- decreased hematocrit / IMPC
- increased mean platelet volume / IMPC
- decreased heart rate / IMPC
- decreased circulating glucose level / IMPC
- increased leukocyte cell number / IMPC
- small thymus / IMPC
- increased liver weight / IMPC
- decreased circulating serum albumin level / IMPC
- decreased body length / IMPC
- abnormal colon morphology / IMPC
MGI phenotypes (gene matching)
- extramedullary hematopoiesis / MGI
- enlarged spleen / MGI
- enlarged lymph nodes / MGI
- premature death / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal macrophage morphology / MGI
- abnormal macrophage physiology / MGI
- abnormal lysosome physiology / MGI
- immune system phenotype / MGI
- increased macrophage cell number / MGI
- increased histiocytic sarcoma incidence / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
- myeloid hyperplasia / MGI
- increased macrophage apoptosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).